Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.70 USD
−190.28 M USD
280.32 M USD
50.22 M
About CareDx, Inc.
Sector
Industry
CEO
John W. Hanna
Website
Headquarters
Brisbane
Founded
1998
FIGI
BBG006JS5785
CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CDNA is 20.61 USD — it has increased by 0.74% in the past 24 hours. Watch CareDx, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CareDx, Inc. stocks are traded under the ticker CDNA.
CDNA stock has fallen by −14.48% compared to the previous week, the month change is a −3.34% fall, over the last year CareDx, Inc. has showed a 85.68% increase.
We've gathered analysts' opinions on CareDx, Inc. future price: according to them, CDNA price has a max estimate of 40.00 USD and a min estimate of 28.00 USD. Watch CDNA chart and read a more detailed CareDx, Inc. stock forecast: see what analysts think of CareDx, Inc. and suggest that you do with its stocks.
CDNA reached its all-time high on Jan 20, 2021 with the price of 99.83 USD, and its all-time low was 0.76 USD and was reached on Apr 28, 2017. View more price dynamics on CDNA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CDNA stock is 5.22% volatile and has beta coefficient of 1.87. Track CareDx, Inc. stock price on the chart and check out the list of the most volatile stocks — is CareDx, Inc. there?
Today CareDx, Inc. has the market capitalization of 1.10 B, it has decreased by −8.44% over the last week.
Yes, you can track CareDx, Inc. financials in yearly and quarterly reports right on TradingView.
CareDx, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
CDNA earnings for the last quarter are −0.14 USD per share, whereas the estimation was −0.25 USD resulting in a 43.14% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about CareDx, Inc. earnings.
CareDx, Inc. revenue for the last quarter amounts to 82.88 M USD, despite the estimated figure of 80.04 M USD. In the next quarter, revenue is expected to reach 82.15 M USD.
CDNA net income for the last quarter is −7.41 M USD, while the quarter before that showed −1.39 M USD of net income which accounts for −431.42% change. Track more CareDx, Inc. financial stats to get the full picture.
No, CDNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 20, 2024, the company has 643.00 employees. See our rating of the largest employees — is CareDx, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CareDx, Inc. EBITDA is −39.66 M USD, and current EBITDA margin is −29.28%. See more stats in CareDx, Inc. financial statements.
Like other stocks, CDNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CareDx, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CareDx, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CareDx, Inc. stock shows the buy signal. See more of CareDx, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.